The 340B Contract Pharmacy Saga

coapharm2020-09-24T15:59:31+00:00September 24, 2020|

Drug Discount Programs Create More Cloud In Quest For Transparency

coapharm2020-09-24T15:58:26+00:00September 24, 2020|

A Deal on Drug Prices Undone by White House Insistence on ‘Trump Cards’

coapharm2020-09-21T13:01:11+00:00September 21, 2020|

Comparing Patient OOP Spending for Specialty Drugs in Medicare Part D and Employer-Sponsored Insurance

coapharm2020-09-21T13:00:22+00:00September 21, 2020|

Trump’s last-ditch drug pricing moves could help him in November. But they likely won’t save Americans money

coapharm2020-09-15T13:14:59+00:00September 15, 2020|

340B Action Heats Up: New Developments From the Courts, Administration and Drug Makers

coapharm2020-09-15T13:10:43+00:00September 15, 2020|

Sharing drug rebates with Medicare Part D patients: Why and how

coapharm2020-09-15T13:09:37+00:00September 15, 2020|

Trump Issues Expansive Order Aimed at Lowering Drug Prices

coapharm2020-09-14T20:46:05+00:00September 14, 2020|

With election looming, Trump releases major, last-ditch drug pricing order

coapharm2020-09-14T20:45:21+00:00September 14, 2020|

Keep the government out of pharmaceutical drug manufacturing

coapharm2020-09-14T20:44:38+00:00September 14, 2020|